Filing Details

Accession Number:
0001493152-22-023522
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-19 08:00:26
Reporting Period:
2022-08-17
Accepted Time:
2022-08-19 08:00:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472122 Andrew Arno C/O Oncocyte Corporation
15 Cushing
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2022-08-17 7,500 $0.90 15,000 No 4 P Indirect See footnote
Common Stock, No Par Value Acquisiton 2022-08-17 7,500 $0.90 15,000 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. The price of $0.90 per share represents a weighted average of prices ranging from $0.88 to $0.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The shares of common stock are held by JBA Investments LLC. The Reporting Person is the Manager of JBA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
  3. The shares of common stock are held by MJA Investments LLC. The Reporting Person is the Manager of MJA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.